v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (6,993,647) $ (5,355,869)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,724 1,725
Stock-based compensation 943,649 631,533
Shares issued for services 50,000
Loss on conversion of notes 92,959
Amortization of debt discount 20,000
Changes in operating assets and liabilities:    
Prepaid expense 34,285 (130,882)
Accounts payable 332,278 (440,337)
Accrued expenses 71,462 (838,428)
Deferred revenue (32,000)
Net cash used in operating activities (5,610,249) (6,001,299)
Cash flows from investing activities:    
Purchases of property and equipment
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from issuance of common stock and warrants, net of issuance costs 8,315,686 7,293,651
Proceeds from exercise of warrants 105,816 1,494,658
Proceeds from notes payable 100,000
Payments of notes payable (319,950)
Proceeds from short term insurance financing 561,885 697,534
Payments of short term insurance financing (561,885) (697,534)
Net cash provided by financing activities 8,421,502 8,568,359
Net increase in cash and cash equivalents 2,811,253 2,567,060
Cash and cash equivalents, beginning of period 2,624,730 57,670
Cash and cash equivalents, end of period 5,435,983 2,624,730
Supplemental cash flow information:    
Cash paid for interest 18,158 93,916
Cash paid for taxes
Supplemental non-cash activity    
Issuance of common stock upon conversion of notes payable $ 1,535,615

Source

HTML PDF
ZIP